External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Lupus Academy 2026
Roche and Genentech at

Lupus Academy 2026

September 03 - September 05
Bratislava, Slovakia / Virtual (Hybrid)
lupus.academy
We will be contributing to topics related to
Rheumatology Nephrology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
08:00 AM
Duration 3mins Bratislava, Slovakia
Obinutuzumab Induces Histologic Remission and Deep Kidney Parenchymal B-cell Depletion in Patients With Lupus Nephritis: Exploratory Analyses of the Phase III REGENCY Trial
Richard A. Furie, Brad H. Rovin, Elsa Martins, Cary D. Austin, Harini Raghu, Caleb Chan, Patrick S. Chang, Jay P. Garg, Valeria Alberton, Mittermayer B. Santiago, Gustavo Aroca-Martínez, Fedra I. Palazuelos, Teresa Baczkowska, Jose Alfaro, Jorge Ravelo-Hernández, Luis F. Pinto, Eduardo H. Albiero, Christopher Larsen, Bongin Yoo, Jennifer Pulley, Andrew Thorley, Thomas Schindler, Theodore A. Omachi, William F. Pendergraft, Ana Malvar
Nephrology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:30 PM
Duration 2mins Bratislava, Slovakia
Obinutuzumab Reduces Fatigue and Improves Health-Related Quality of Life in ALLEGORY, a Phase III Trial in Systemic Lupus Erythematosus
Ronald Van Vollenhoven, Laurent Arnaud, Jeannette Anderson, Marta Mosca, Luca Iaccarino, Josefina Cortés, Sandrine Jousse-Joulin, Olga Mitrofanova, Oliver Meier, Gene Wallenstein, Peiqing Yu, Jay P. Garg, Maria Dall’Era, Richard A. Furie, Edward M. Vital, Anca Dinu Askanase, Eric Morand
Rheumatology | Systemic Lupus Erythematosus

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 3mins Bratislava, Slovakia
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus: ToplineResults of the Phase III ALLEGORY Trial
Richard A. Furie, Maria Dall’Era, Edward M. Vital, Jay P. Garg, Adolfina E. Zuta Santillán, Mittermayer B. Santiago, Stella Botha, Piotr Leszczyński, Viviane Angelina de Souza, Zahir Amoura, Maria Antonietta D’Agostino, Sunil Kumar, Julie Rae, Huiyan A. Mao, Felix Erblang, Oliver Meier, Justine C. Maller, Anca D. Askanase
Rheumatology | Systemic Lupus Erythematosus

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.